Literature DB >> 14654792

Repression of mRNA for the PLK cell cycle gene after DNA damage requires BRCA1.

Anne Hansen Ree1, Ase Bratland, Ragnhild V Nome, Trond Stokke, Øystein Fodstad.   

Abstract

DNA damage activates the G2 cell cycle checkpoint to allow time for DNA repair before mitotic entry. The mechanism involves inhibition of the enzymatic activity for polo-like kinase 1 (Plk1), rendering Cdc25C with a basal phosphatase activity that is insufficient for converting Cdc2 to the fully active G2/M transition kinase. We found that cell cycle arrest at the G2/M boundary after ionizing radiation (IR) of breast carcinoma cells may involve repression of the gene for Plk1, PLK, mediated by the tumor-suppressor protein BRCA1. The p53-defective MT-1 cell line had an apparent accumulation of G2/M phase cells 12 h after irradiation. This response was preceded by a transient downregulation of PLK mRNA expression with a barely detectable level 6 h after exposure to IR but recovered after 12 h. A significantly lower fraction of irradiated BRCA1(-/-) HCC1937 cells arrested in the G2/M phase after 12 h, and the transient response of PLK mRNA was also considerably impaired. After reconstitution of wild-type BRCA1 in the HCC1937 cells however, downregulation of PLK mRNA as well as Plk1 protein expression after IR was restored. Moreover, the suppression of PLK mRNA expression 6 h after irradiation was completely abolished by the specific CHEK1 kinase inhibitor UCN-01, further indicating that the effector mechanism of DNA damage on PLK signals through BRCA1 and its downstream CHEK1. Our observations provide new information about the diversity of regulatory mechanisms governed by BRCA1 in DNA damage checkpoint control.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14654792     DOI: 10.1038/sj.onc.1207000

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

1.  BRCA1 interaction of centrosomal protein Nlp is required for successful mitotic progression.

Authors:  Shunqian Jin; Hua Gao; Lucia Mazzacurati; Yang Wang; Wenhong Fan; Qiang Chen; Wei Yu; Mingrong Wang; Xueliang Zhu; Chuanmao Zhang; Qimin Zhan
Journal:  J Biol Chem       Date:  2009-06-09       Impact factor: 5.157

Review 2.  Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy.

Authors:  Klaus Strebhardt
Journal:  Nat Rev Drug Discov       Date:  2010-08       Impact factor: 84.694

3.  Polo-like kinase 1 as predictive marker and therapeutic target for radiotherapy in rectal cancer.

Authors:  Franz Rödel; Sarah Keppner; Gianni Capalbo; Robina Bashary; Manfred Kaufmann; Claus Rödel; Klaus Strebhardt; Birgit Spänkuch
Journal:  Am J Pathol       Date:  2010-06-25       Impact factor: 4.307

4.  Absence of tumor-specific over-expression of Polo-like kinase 1 (Plk1) in major non-Hodgkin lymphoma and relatively low expression of Plk1 in nasal NK/T cell lymphoma.

Authors:  Hidenori Imai; Koichi Sugimoto; Yasushi Isobe; Makoto Sasaki; Hajime Yasuda; Kengo Takeuchi; Shinji Nakamura; Yuko Kojima; Junichi Tomomatsu; Kazuo Oshimi
Journal:  Int J Hematol       Date:  2009-05-19       Impact factor: 2.490

5.  Polo-like kinase 1 is involved in invasion through extracellular matrix.

Authors:  Aylin Rizki; Joni D Mott; Mina J Bissell
Journal:  Cancer Res       Date:  2007-12-01       Impact factor: 12.701

6.  Alternative transcript initiation and splicing as a response to DNA damage.

Authors:  Carl N Sprung; Jason Li; Daniel Hovan; Michael J McKay; Helen B Forrester
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

7.  Radiosensitization of colorectal carcinoma cell lines by histone deacetylase inhibition.

Authors:  Kjersti Flatmark; Ragnhild V Nome; Sigurd Folkvord; Ase Bratland; Heidi Rasmussen; Mali Strand Ellefsen; Øystein Fodstad; Anne Hansen Ree
Journal:  Radiat Oncol       Date:  2006-08-03       Impact factor: 3.481

8.  A cautionary tale of sense-antisense gene pairs: independent regulation despite inverse correlation of expression.

Authors:  Ashish Goyal; Evgenij Fiškin; Tony Gutschner; Maria Polycarpou-Schwarz; Matthias Groß; Julia Neugebauer; Minakshi Gandhi; Maiwen Caudron-Herger; Vladimir Benes; Sven Diederichs
Journal:  Nucleic Acids Res       Date:  2017-12-01       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.